FutureChem Co.Ltd
FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products i… Read more
FutureChem Co.Ltd (220100) - Total Liabilities
Latest total liabilities as of September 2025: ₩19.40 Billion KRW
Based on the latest financial reports, FutureChem Co.Ltd (220100) has total liabilities worth ₩19.40 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
FutureChem Co.Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how FutureChem Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
FutureChem Co.Ltd Competitors by Total Liabilities
The table below lists competitors of FutureChem Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DongGuan Winnerway Industrial Zone Ltd
SHE:000573
|
China | CN¥501.23 Million |
|
Genie Energy Ltd
NYSE:GNE
|
USA | $205.30 Million |
|
ZJBC Information Technology Co Ltd
SHE:000889
|
China | CN¥818.07 Million |
|
Oriental Union Chemical Corp
TW:1710
|
Taiwan | NT$19.43 Billion |
|
Nathans Famous Inc
NASDAQ:NATH
|
USA | $66.21 Million |
|
Chengdu Huasun Group Inc Ltd
SHE:000790
|
China | CN¥911.88 Million |
|
Pubmatic Inc
NASDAQ:PUBM
|
USA | $431.13 Million |
|
Banco Products (I) Limited
NSE:BANCOINDIA
|
India | ₹14.43 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down FutureChem Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how FutureChem Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for FutureChem Co.Ltd (2016–2024)
The table below shows the annual total liabilities of FutureChem Co.Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩20.04 Billion | +124.71% |
| 2023-12-31 | ₩8.92 Billion | -52.00% |
| 2022-12-31 | ₩18.58 Billion | -23.91% |
| 2021-12-31 | ₩24.42 Billion | -37.52% |
| 2020-12-31 | ₩39.08 Billion | -24.91% |
| 2019-12-31 | ₩52.05 Billion | +9.37% |
| 2018-12-31 | ₩47.59 Billion | +440.85% |
| 2017-12-31 | ₩8.80 Billion | +458.64% |
| 2016-12-31 | ₩1.58 Billion | -- |